111 related articles for article (PubMed ID: 38328119)
1. Epitranscriptomic Reader YTHDF2 Regulates SEK1(
Malovic E; Ealy A; Hsu PJ; Sarkar S; Miller C; Rokad D; Goeser C; Hartman AK; Zhu A; Palanisamy B; Zenitsky G; Jin H; Anantharam V; Kanthasamy A; He C; Kanthasamy AG
bioRxiv; 2024 Jan; ():. PubMed ID: 38328119
[TBL] [Abstract][Full Text] [Related]
2. m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.
Yu R; Li Q; Feng Z; Cai L; Xu Q
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875984
[TBL] [Abstract][Full Text] [Related]
3. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
4. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 mediates LPS-induced osteoclastogenesis and inflammatory response via the NF-κB and MAPK signaling pathways.
Fang C; He M; Li D; Xu Q
Cell Signal; 2021 Sep; 85():110060. PubMed ID: 34089814
[TBL] [Abstract][Full Text] [Related]
6. Senolytics Cocktail Dasatinib and Quercetin Alleviate Human Umbilical Vein Endothelial Cell Senescence via the TRAF6-MAPK-NF-κB Axis in a YTHDF2-Dependent Manner.
Fan T; Du Y; Zhang M; Zhu AR; Zhang J
Gerontology; 2022; 68(8):920-934. PubMed ID: 35468611
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
8. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
[TBL] [Abstract][Full Text] [Related]
9. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
[TBL] [Abstract][Full Text] [Related]
10. Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation.
Wada T; Nakagawa K; Watanabe T; Nishitai G; Seo J; Kishimoto H; Kitagawa D; Sasaki T; Penninger JM; Nishina H; Katada T
J Biol Chem; 2001 Aug; 276(33):30892-7. PubMed ID: 11418587
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 Is Downregulated in Response to Host Shutoff Induced by DNA Virus Infection and Regulates Interferon-Stimulated Gene Expression.
Hesser CR; Walsh D
J Virol; 2023 Mar; 97(3):e0175822. PubMed ID: 36916936
[TBL] [Abstract][Full Text] [Related]
12. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes.
Sarkar S; Malovic E; Harischandra DS; Ngwa HA; Ghosh A; Hogan C; Rokad D; Zenitsky G; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurotoxicology; 2018 Jan; 64():204-218. PubMed ID: 28539244
[TBL] [Abstract][Full Text] [Related]
13. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.
Guan Z; Buckman SY; Pentland AP; Templeton DJ; Morrison AR
J Biol Chem; 1998 May; 273(21):12901-8. PubMed ID: 9582321
[TBL] [Abstract][Full Text] [Related]
14. The m6A reader YTHDF2 alleviates the inflammatory response by inhibiting IL-6R/JAK2/STAT1 pathway-mediated high-mobility group box-1 release.
Zeng Z; Lan Y; Zhang L; Chen Y; Gong Y; Zuo F; Li J; Luo G; Peng Y; Yuan Z
Burns Trauma; 2023; 11():tkad023. PubMed ID: 38026444
[TBL] [Abstract][Full Text] [Related]
15. FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.
Zhou SM; Li JZ; Chen HQ; Zeng Y; Yuan WB; Shi Y; Wang N; Fan J; Zhang Z; Xu Y; Cao J; Liu WB
Environ Pollut; 2023 May; 325():121393. PubMed ID: 36878272
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of N
Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
[TBL] [Abstract][Full Text] [Related]
18. The biological function of m6A reader YTHDF2 and its role in human disease.
Wang JY; Lu AQ
Cancer Cell Int; 2021 Feb; 21(1):109. PubMed ID: 33593354
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.
Li J; Wu L; Pei M; Zhang Y
J Ovarian Res; 2020 Sep; 13(1):111. PubMed ID: 32948220
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]